Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa ; volume:21 ; number:1 ; day:6 ; month:4 ; year:2021 ; pages:1-11 ; date:12.2021
BMC health services research ; 21, Heft 1 (6.4.2021), 1-11, 12.2021
- Urheber
-
Miot, Jacqui
Leong, Trudy
Takuva, Simbarashe
Parrish, Andrew
Dawood, Halima
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-021-06268-9
- URN
-
urn:nbn:de:101:1-2021052819463087968481
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miot, Jacqui
- Leong, Trudy
- Takuva, Simbarashe
- Parrish, Andrew
- Dawood, Halima
- SpringerLink (Online service)
Ähnliche Objekte (12)
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
Microglia are not protective against cryptococcal meningitis
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
Cryptococcal meningitis in a goat – a case report
Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis
Prevalence of cryptococcal meningitis and lymphadenitis among PLHA
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3
Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
Microglia are not protective against cryptococcal meningitis
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
Cryptococcal meningitis in a goat – a case report
Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis
Prevalence of cryptococcal meningitis and lymphadenitis among PLHA
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3
Identification of Disease-Associated Cryptococcal Proteins Reactive With Serum IgG From Cryptococcal Meningitis Patients
Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients
Ventriculoperitoneal shunts in non-HIV cryptococcal meningitis
Microglia are not protective against cryptococcal meningitis
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis
Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in Uganda
Cryptococcal meningitis in a goat – a case report
Diagnostic Value of Latex Agglutination in Cryptococcal Meningitis
Prevalence of cryptococcal meningitis and lymphadenitis among PLHA
Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3